Regnum Corp. Share Price Other OTC
Equities
RGMP
US75915R1068
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 3.1M 245M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net Debt 2021 | 22.06K 1.74M | Net Debt 2022 | 773K 60.98M | EV / Sales 2022 | - |
P/E ratio 2021 |
-13
x | P/E ratio 2022 |
-3.97
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 1.18% |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |